Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
3
×
boston blog main
boston top stories
san francisco blog main
startups
acute myeloid leukemia
adverum biotechnologies
ally bridge group
alnylam pharmaceuticals
ambit biosciences
athena countouriotis
beijing
big data analytics
blackrock
boston
brett zbar
brii bio
brii biosciences
bristol-myers squibb
casdin capital
china
clinical trials
cormorant asset management
daiichi sankyo
deals
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
glaxosmithkline
goldfinch bio
gsk
halozyme therapeutics
hbm healthcare investments
hbm partners
hepatitis b
irving investors
jay ghosh
What
drug
3
×
million
3
×
new
3
×
biotech
medicines
raised
year
adds
alliance
analysis
areas
athena
bio
biosciences
bio’s
brii
bring
cancer
ceo
chief
company
countouriotis
develop
disease
diseases
earlier
employing
financing
genetic
gets
goldfinch
hepatitis
infectious
ipo
kidney
later
launched
lead
medical
mezzanine
Language
unset
Current search:
drug
×
new
×
" national top stories "
×
million
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push